These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9884908)

  • 41. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
    Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Common 1H-MRS Characteristics in Patients With Alzheimer's Disease and Vascular Dementia Diagnosed With Kidney Essence Deficiency Syndrome: A Preliminary Study.
    Guo Z; Liu X; Cao Y; Hou H; Chen X; Chen Y; Huang F; Chen W
    Altern Ther Health Med; 2017 May; 23(3):12-18. PubMed ID: 28236618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gender comparisons of cognitive performances among vascular dementia, Alzheimer disease, and older adults without dementia.
    Buckwalter JG; Rizzo AA; McCleary R; Shankle R; Dick M; Henderson VW
    Arch Neurol; 1996 May; 53(5):436-9. PubMed ID: 8624219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.
    Zuliani G; Ranzini M; Guerra G; Rossi L; Munari MR; Zurlo A; Volpato S; Atti AR; Blè A; Fellin R
    J Psychiatr Res; 2007 Oct; 41(8):686-93. PubMed ID: 16600299
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia.
    Parnetti L; Palumbo B; Cardinali L; Loreti F; Chionne F; Cecchetti R; Senin U
    Neurosci Lett; 1995 Jan; 183(1-2):43-5. PubMed ID: 7746484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.
    Rinaldi P; Polidori MC; Metastasio A; Mariani E; Mattioli P; Cherubini A; Catani M; Cecchetti R; Senin U; Mecocci P
    Neurobiol Aging; 2003 Nov; 24(7):915-9. PubMed ID: 12928050
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls.
    Folin M; Baiguera S; Gallucci M; Conconi MT; Di Liddo R; Zanardo A; Parnigotto PP
    Biogerontology; 2005; 6(4):255-60. PubMed ID: 16333759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin E for Alzheimer's disease and mild cognitive impairment.
    Isaac MG; Quinn R; Tabet N
    Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alzheimer's disease treated patients showed different patterns for oxidative stress and inflammation markers.
    Gubandru M; Margina D; Tsitsimpikou C; Goutzourelas N; Tsarouhas K; Ilie M; Tsatsakis AM; Kouretas D
    Food Chem Toxicol; 2013 Nov; 61():209-14. PubMed ID: 23871825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular compliance is reduced in vascular dementia and not in Alzheimer's disease.
    Dhoat S; Ali K; Bulpitt CJ; Rajkumar C
    Age Ageing; 2008 Nov; 37(6):653-9. PubMed ID: 18703522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apolipoprotein E and intronic polymorphism of presenilin 1 and alpha-1-antichymotrypsin in Alzheimer's disease and vascular dementia.
    Rodriguez Martin T; Calella AM; Silva S; Munna E; Modena P; Chiesa R; Terrevazzi S; Ruggieri RM; Palermo R; Piccoli F; Confalonieri R; Tiraboschi P; Fragiacomo C; Quadri P; Lucca U; Forloni G
    Dement Geriatr Cogn Disord; 2000; 11(5):239-44. PubMed ID: 10940674
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis.
    Schrag M; Mueller C; Zabel M; Crofton A; Kirsch WM; Ghribi O; Squitti R; Perry G
    Neurobiol Dis; 2013 Nov; 59():100-10. PubMed ID: 23867235
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease.
    Polidori MC; Mecocci P
    J Alzheimers Dis; 2002 Dec; 4(6):517-22. PubMed ID: 12629261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A promising method to distinguish vascular dementia from Alzheimer's disease with standardized low-resolution brain electromagnetic tomography and quantitative EEG.
    Wu L; Wu L; Chen Y; Zhou J
    Clin EEG Neurosci; 2014 Jul; 45(3):152-7. PubMed ID: 24214287
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.
    Neri S; Signorelli SS; Torrisi B; Pulvirenti D; Mauceri B; Abate G; Ignaccolo L; Bordonaro F; Cilio D; Calvagno S; Leotta C
    Clin Ther; 2005 Nov; 27(11):1764-73. PubMed ID: 16368447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasma cortisol levels in elderly female subjects with Alzheimer's disease: a cross-sectional and longitudinal study.
    Umegaki H; Ikari H; Nakahata H; Endo H; Suzuki Y; Ogawa O; Nakamura A; Yamamoto T; Iguchi A
    Brain Res; 2000 Oct; 881(2):241-3. PubMed ID: 11036168
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of vascular lesions on cognition in Alzheimer's disease: a community-based study.
    Riekse RG; Leverenz JB; McCormick W; Bowen JD; Teri L; Nochlin D; Simpson K; Eugenio C; Larson EB; Tsuang D
    J Am Geriatr Soc; 2004 Sep; 52(9):1442-8. PubMed ID: 15341544
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of vascular dementia and Alzheimer disease: a functional transcranial Doppler ultrasonographic study.
    Asil T; Uzuner N
    J Ultrasound Med; 2005 Aug; 24(8):1065-70. PubMed ID: 16040820
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia.
    Bär KJ; Franke S; Wenda B; Müller S; Kientsch-Engel R; Stein G; Sauer H
    Neurobiol Aging; 2003; 24(2):333-8. PubMed ID: 12498967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Study of plasma antioxidant status in Alzheimer's disease.
    Pulido R; Jiménez-Escrig A; Orensanz L; Saura-Calixto F; Jiménez-Escrig A
    Eur J Neurol; 2005 Jul; 12(7):531-5. PubMed ID: 15958093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.